Jan Hanus

Title: Jan Hanus: Innovator in Pharmaceutical Chemistry

Introduction

Jan Hanus is a notable inventor based in Praha, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on nitrogen heterocyclic derivatives. His research focuses on developing new medicaments that can address various health challenges.

Latest Patents

Jan Hanus holds a patent for "Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof." This patent encompasses various substituted nitrogen heterocyclic derivatives and their pharmaceutically acceptable salt derivatives. These compounds are designed for use as medicaments, specifically targeting applications as antimitotic, anti-viral, anti-cancer, anti-degenerative, immunosuppressive, and anti-microbial drugs or vaccines. The patent highlights several families of heterocyclic derivatives, including pyrrolopyrimidines, pyrazolopyrimidines, purines, and imidazopyridines. Notably, certain tri-substituted and tetra-substituted purines and pyrazolopyrimidines, along with their deaza analogues, are provided for inhibiting cyclin-dependent kinase (cdk) proteins, viruses, and immunostimulation.

Career Highlights

Jan Hanus is affiliated with the Ustav Experimentalni Botaniky Av-cr, where he continues to advance his research in pharmaceutical applications. His work has garnered attention for its potential impact on drug development and therapeutic strategies.

Collaborations

Jan has collaborated with esteemed colleagues, including Vladimír Krystof and Marián Hajdúch, contributing to a rich environment of innovation and research.

Conclusion

Jan Hanus exemplifies the spirit of innovation in pharmaceutical chemistry through his groundbreaking work on nitrogen heterocyclic derivatives. His contributions have the potential to significantly enhance the development of new therapeutic agents.